Editorial: Cancer Care Delivery and Women’s Health: Beyond the Patient and Provider Relationship

par Temkin, Sarah M.
Publié dans Front Oncol (2017)

Distant recurrence in a patient with polyp-confined stage IA serous endometrial carcinoma treated with adjuvant chemotherapy: A case report and review of literature

par Welp, Annalyn, Temkin, Sarah, Sullivan, Stephanie
Publié dans Gynecol Oncol Rep (2019)

Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer

par Terplan, Mishka, Temkin, Sarah, Tergas, Ana, Lengyel, Ernst
Publié 2008

The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?

par Temkin, Sarah M., Minasian, Lori, Noone, Anne-Michelle
Publié dans Front Oncol (2016)

Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: a joint American Gynecological and Obstetrical Society and Council of Uni...

par Terplan, Mishka, van Dis, Jane, Temkin, Sarah M.
Publié dans Am J Obstet Gynecol (2021)

Ovarian cancer prevention in high risk women

par Temkin, Sarah M., Bergstrom, Jennifer, Samimi, Goli, Minasian, Lori
Publié dans Clin Obstet Gynecol (2017)

Black and White Women in Maryland Receive Different Treatment for Cervical Cancer

par Fleming, Saroj, Schluterman, Nicholas H., Tracy, J. Katthleen, Temkin, Sarah M.
Publié 2014

The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years

par Gibson, Steven J., Fleming, Gini F., Temkin, Sarah M., Chase, Dana M.
Publié dans Front Oncol (2016)

Reducing Overtreatment in Gynecologic Oncology: The Case for Less in Endometrial and Ovarian Cancer

par Temkin, Sarah M., Tanner, Edward J., Dewdney, Summer B., Minasian, Lori M.
Publié dans Front Oncol (2016)

Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future

par Fields, Emma C., McGuire, William P., Lin, Lilie, Temkin, Sarah M.
Publié dans Front Oncol (2017)

Serial Sectioning of the Fallopian Tube Allows for Improved Identification of Primary Fallopian Tube Carcinoma

par Lengyel, Ernst, Fleming, Saroj, McEwen, Kelsey A, Montag, Anthony, Temkin, Sarah M.
Publié 2012

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons

par Majithia, Neil, Temkin, Sarah M., Ruddy, Kathryn J., Beutler, Andreas S., Hershman, Dawn L., Loprinzi, Charles L.
Publié dans Support Care Cancer (2015)

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: The role of individual-level and contextual social determinants

par Moss, Jennifer L., Murphy, Jeanne, Filiaci, Virginia L., Wenzel, Lari B., Minasia, Lori, Temkin, Sarah M.
Publié dans Support Care Cancer (2018)

Body Image, Sexuality, and Sexual Functioning in Women with Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research

par Wilson, Christina M., McGuire, Deborah B., Rodgers, Beth L., Elswick, R.K., Temkin, Sarah M.
Publié dans Cancer Nurs (2021)

Fatty acid oxidation: An emerging facet of metabolic transformation in cancer

par Ma, Yibao, Temkin, Sarah M., Hawkridge, Adam M., Guo, Chunqing, Wang, Wei, Wang, Xiang-Yang, Fang, Xianjun
Publié dans Cancer Lett (2018)

Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876

par Ma, Yibao, Wang, Wei, Idowu, Michael O., Oh, Unsong, Wang, Xiang-Yang, Temkin, Sarah M., Fang, Xianjun
Publié dans Cancers (Basel) (2018)

Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer

par Rubinsak, Lisa A., Terplan, Mishka, Martin, Caitlin E., Fields, Emma C., McGuire, William P., Temkin, Sarah M.
Publié dans Gynecol Oncol Rep (2019)

Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models

par Wise, Hannah C., Iyer, Gopakumar V., Moore, Kathleen, Temkin, Sarah M., Gordon, Sarah, Aghajanian, Carol, Grisham, Rachel N.
Publié dans Sci Rep (2019)

Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer

par Sutton, Arnethea L., Hurtado-de-Mendoza, Alejandra, Quillin, John, Rubinsak, Lisa, Temkin, Sarah M., Gal, Tamas, Sheppard, Vanessa B.
Publié dans J Womens Health (Larchmt) (2020)

The “Value” of Value in Gynecologic Oncology Practice in the United States: A Society of Gynecologic Oncology Evidence-based Review and Recommendations

par Cohn, David E., Ko, Emily, Meyer, Larissa A, Wright, Jason D., Temkin, Sarah, Foote, Jonathan, Jones, Nate, Havrilesky, Laura J.
Publié dans Gynecol Oncol (2017)